Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "DCGI"

143 News Found

Molbio has pioneered point of care molecular testing: Sriram Natarajan
interviews | November 22, 2021

Molbio has pioneered point of care molecular testing: Sriram Natarajan

Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil


Sun Pharma to introduce molnupiravir in India
Drug Approval | November 12, 2021

Sun Pharma to introduce molnupiravir in India

The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India


Novaerus devices reduce bio-burden in healthcare facilities: Dilip Patil, Partner, Trivector Biomed
interviews | November 05, 2021

Novaerus devices reduce bio-burden in healthcare facilities: Dilip Patil, Partner, Trivector Biomed

Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.


Glenmark launches novel fixed-dose combination for diabetes
Drug Approval | October 26, 2021

Glenmark launches novel fixed-dose combination for diabetes

It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination


Covaxin for kids gets nod, final approval awaited
Drug Approval | October 12, 2021

Covaxin for kids gets nod, final approval awaited

The two doses of Covaxin are likely to be administered to children with a gap of 28 days


Cadila Healthcare receives permission to conduct Phase III trials for two-dose ZyCoV-D
News | October 06, 2021

Cadila Healthcare receives permission to conduct Phase III trials for two-dose ZyCoV-D

The company has already received the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D to be administered in three doses on August 20


Novavax and Serum seek WHO approval for Covid-19 vaccine
News | September 24, 2021

Novavax and Serum seek WHO approval for Covid-19 vaccine

It is a recombinant nanoparticle protein-based vaccine


DGCI gives a go-ahead for Phase III Sputnik Light trials
News | September 16, 2021

DGCI gives a go-ahead for Phase III Sputnik Light trials

The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines


New law to regulate drugs  and medical devices soon
Policy | September 09, 2021

New law to regulate drugs and medical devices soon

The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry


DGCI approves Hetero’s Tocilizumab
Drug Approval | September 06, 2021

DGCI approves Hetero’s Tocilizumab

Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month